| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | EVP, Chief Strategy Officer | Chief Strategy Officer
2 companies
Gosebruch Henry O is a President &CEO at Neumora Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 2 buys and 46 sells.
Estimated insider holdings value: $21.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 | NMRA Neumora Therapeutics, Inc. | President &CEO | Buy | 15,000 | $12.62 | $189,370.50 | New | +22.6% | +1.9% | |
| May 16, 2022 | ABBV Abbvie Inc. | EVP, Chief Strategy Officer | Sale+OE | 83,960 | $155.00 | $13,013,800.00 | -83.5% | -7.6% | -6.0% | |
| Mar 1, 2022 | ABBV Abbvie Inc. | EVP, Chief Strategy Officer | Sell | 25,000 | $147.29 | $3,682,188.65 | -23.8% | +0.6% | +8.1% | |
| Mar 1, 2022 | ABBV Abbvie Inc. | EVP, Chief Strategy Officer | Sell | 15,000 | $148.26 | $2,223,835.93 | -10.0% | +0.6% | +8.1% | |
| Nov 20, 2020 | ABBV Abbvie Inc. | EVP, Chief Strategy Officer | Sell | 40,000 | $99.38 | $3,975,046.00 | -35.4% | - | - | |
| Jul 29, 2019 | ABBV Abbvie Inc. | EVP, Chief Strategy Officer | Buy | 30,000 | $67.28 | $2,018,385.00 | +65.6% | - | - | |
| Nov 29, 2018 | ABBV Abbvie Inc. | EVP, Chief Strategy Officer | Sell | 42,450 | $90.10 | $3,824,940.27 | -58.3% | - | - | |
| Oct 30, 2017 | ABBV Abbvie Inc. | Chief Strategy Officer | Sell | 18,300 | $90.55 | $1,657,037.10 | -6.1% | - | - | |
| Jul 31, 2017 | ABBV Abbvie Inc. | Chief Strategy Officer | Sell | 18,000 | $70.09 | $1,261,638.37 | -0.7% | - | - | |
| Jul 31, 2017 | ABBV Abbvie Inc. | Chief Strategy Officer | Sell | 300 | $70.42 | $21,127.00 | -0.2% | - | - |